Measles Outbreak Linked to Youth Soccer Event

Keep Vaccines Up-to-Date to Avoid Risks from 'Imported' Measles

Newswise — An outbreak of measles at an international youth sporting event illustrates the risks of with "imported" measles, according to a study in the September issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

Measles "imported" from countries with lower vaccination rates can readily cause outbreaks in the United States, the researchers write, including measles in vaccinated adults and cases transmitted during air travel. The study was led by Dr. Tai-Ho Chen of the Centers for Disease Control and Prevention (CDC). Measles in Young Player Leads to Public Health InvestigationThe 2007 outbreak began when a Japanese child attending an international youth sporting event in Pennsylvania developed a fever with the typical measles rash. The child was immediately placed in isolation; a few days later, tests confirmed the diagnosis of measles.

Public health officials responded promptly, launching an investigation that included nearly 500 players, coaches, staff, and others attending the sporting event. About 40 percent of these contacts did not have evidence of "presumptive measles immunity"—they had not either had measles or been vaccinated against it. All were either vaccinated or tested to see if they had immunity.

Vaccination records had been requested for all children attending the event—however, for most participants, this information was missing. Even when requested again, vaccine information was still not provided for most of the children from international teams.

The investigation was broadened to identify others who might have been exposed to the sick child during or after his trip. Measles also developed in another Japanese child who had traveled with the team. All members of the Japanese team, and another team traveling on the same airplane from Tokyo, were vaccinated. Staff and other guests at the hotel where the child had been staying were advised of their possible exposure; none were apparently infected.

Additional Cases Linked to Exposure during Air TravelFurther tracing efforts identified two people who developed measles after being exposed to the child during air travel. One was a federal airport officer who was probably exposed to the child as he passed through customs. The other was in another passenger who had been seated one row in front of the child on a subsequent flight.

Another case occurred in a man who had worked at the youth sporting event, and subsequently made a number of college visits in Texas. Two students at one of the colleges, who came into contact with the man during his visit, also developed measles. The two students had received routine measles vaccination in childhood; both developed only mild cases of measles.

Further tests were performed to confirm whether these additional patients were all infected with the same measles virus as the original Japanese patient. Of six patients tested, all proved to have the same measles virus genotype.

Through high vaccination rates, measles has been virtually eliminated in the United States. However, there is still a risk of exposure to measles by travelers from other countries—even developed countries such as Japan, where the measles vaccination rate is low and periodic measles outbreaks still occur.

"The findings from this outbreak remind healthcare providers of the potential for measles importation," Dr. Chen and colleagues write. They highlight the need to maintain high levels of measles immunity in the U.S. population—particularly ensuring that all children (and unvaccinated adults) receive two recommended doses of measles vaccine. The investigators conclude, "Improving global measles control through expanded vaccination coverage will reduce morbidity and mortality in other countries and also will reduce the burden of measles in the US."

About The Pediatric Infectious Disease JournalThe Pediatric Infectious Disease Journal® (http://www.pidj.com) is a peer-reviewed, multidisciplinary journal directed to physicians and other health care professionals who manage infectious diseases of childhood. The journal delivers the latest insights on all aspects of infectious disease in children, from state-of-art diagnostic techniques to the most effective drug therapies and other essential treatment protocols. The Pediatric Infectious Disease Journal is official journal of the Pediatric Infectious Diseases Society and the European Society for Paediatric Infectious Diseases.

About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer has 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.